Next-generation sequencing revealed factors associated with cumulative incidence of relapse and leukemia-free survival in patients with newly diagnosed acute myeloid leukemia
Background: Several prognostic biomarkers have been validated for acute myeloid leukemia (AML), a heterogeneous hematopoietic malignancy. However, the factors associated with the cumulative incidence of relapse (CIR) and leukemia-free survival (LFS) in real-world patients with AML have not been well...
Main Authors: | Sai Huang, Peng Chen, Lu Wang, Lingmin Xu, Mingyu Jia, Jing Chen, Nan Wang, Fei Li, Lixia Liu, Jiayue Qin, Chengcheng Wang, Shanbo Cao, Liping Dou, Daihong Liu |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-01-01
|
Series: | Cancer Pathogenesis and Therapy |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2949713222000039 |
Similar Items
-
Next-generation sequencing reveals relapse and leukemia-free survival risks in newly diagnosed acute myeloid leukemia treated with CAG regimen combined with decitabine
by: Sai Huang, et al.
Published: (2024-04-01) -
Venetoclax in adult acute myeloid leukemia
by: Mengci Hu, et al.
Published: (2023-12-01) -
Azacitidine Plus Venetoclax for the Treatment of Relapsed and Newly Diagnosed Acute Myeloid Leukemia Patients
by: Sylvain Garciaz, et al.
Published: (2022-04-01) -
Flumatinib plus venetoclax as an effective therapy for Philadelphia chromosome‐positive acute myeloid leukemia: A case report
by: Si‐Man Huang, et al.
Published: (2023-01-01) -
Spectrum of infections in different regimens of post-induction chemotherapy in acute myeloid leukemia (de-novo): A comparative retrospective study
by: Haya Majid, et al.
Published: (2024-02-01)